Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Infographic

The Efficacy and Safety of an Oral Phosphodiesterase 4B (PDE4B) Inhibitor, BI 1015550, in Patients With Idiopathic Pulmonary Fibrosis (IPF): A Phase 2 Clinical Trial

Reviewed by Elizabeth Volkmann, MD, MS

Advertisement

Advertisement

Advertisement